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Outcome reporting bias in
government-funded RCTs
An-Wen Chan and associates,1 intheir evaluation of outcome report-
ing bias in 48 randomized controlled
trials funded by the Canadian Institutes
of Health Research (CIHR), found that
a high number (median 26) of outcomes
were declared in each protocol, but not
all of these outcomes were reported in
the published papers; in addition, statis-
tically significant efficacy outcomes had
a higher likelihood of being reported
than nonsignificant ones.
Twenty of the 48 studies were
jointly funded by industry and CIHR.
It would be of interest to know whether
the results were consistent between the
2 subgroups of studies, those funded by
government only and those cofunded
by industry.
This work shows that research pro-
moted through public funding is not free
from bias. The explanation of outcome
reporting bias is challenging. In particu-
lar, further investigation is needed to
identify the factors that affect selection
of outcomes between a study’s protocol
and the published report of the study. 
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[The authors respond:]
In response to Pasquale Moja and as-sociates, we would first like to clarify
2 points in their letter. First, it would
be more accurate to state that a median
of 26 outcomes was declared in both
the protocols and the publications,
rather than in the protocols alone. Also,
with regard to the assertion that “re-
search promoted through public fund-
ing is not free from bias,” we would
clarify that it is not the research itself
that is biased, but rather the reporting
of the research.1
Moja and associates ask about the
consistency of results across sources of
funding. We would not expect signifi-
cantly greater deficiencies among trials
that were jointly funded by government
and industry sources, as these studies
were investigator-driven rather than
fully controlled by the industry spon-
sor. Furthermore, formal subgroup
analyses would be underpowered to de-
tect any differences. 
However, we do agree that stratify-
ing the data by funding source would
provide valuable preliminary insight
into factors that might affect selective
outcome reporting. Exploratory post
hoc analyses for efficacy outcomes re-
vealed consistent results across funding
subgroups. The odds ratios for outcome
reporting bias were 3.4 (95% confi-
dence interval [CI] 1.3–9.3) for trials
funded jointly by industry and CIHR
(n = 11 trials) and 2.3 (95% CI 1.1–5.1)
for trials funded by CIHR alone (n = 19
trials). The prevalence of major discrep-
ancies in the specification of primary
outcomes also did not differ significantly
between jointly funded (7/20, 35%) or
CIHR-funded (12/28, 43%) trials. 
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Medical education and
chronic disease
Anton Miller and associates,1 intheir commentary on the need to
improve health care services for chil-
dren with chronic health conditions,
reveal one of the weaknesses of the
medical profession. We have diffi-
culty adapting to new situations, such
as that presented by the increasing
prevalence of chronic disease in our
society. 
Although we can improve patients’
quality of life or soothe the burden of
certain diseases, many chronic condi-
tions simply cannot be cured, and pa-
tients will have to accept that limita-
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